ABBV Congressional Stock Trades
ABBVIE INC
Last disclosed trade Sep 14
Every disclosed trade in ABBV by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.
Sample · the intelligence layer
Pete Sessions · Sold $ABBV · Sep 14 · $15K–$50K
Coldpine’s read
Sessions sits on Financial Services and Oversight, though neither directly oversees pharmaceutical firms like AbbVie. The sale falls in the moderate $15K–$50K range and was held in an IRA subaccount. The 4-day disclosure lag is relatively fast, meaning the market may not have fully absorbed the filing.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $ABBV
Get notified when any member of Congress trades $ABBV. Free, no card, no spam.
The record on $ABBV
Coldpine has parsed 58 disclosed trades in $ABBV by 13 members of Congress, drawn from 43 periodic transaction reports dated Feb 10, 2023 through Sep 14, 2026. That is 57 trades from House members and 1 trade from senators, filed 45 by Democrats and 13 by Republicans.
Of the 58 trades with a known filing lag, 1 was reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 26 days. The longest was 116 days: a $ABBV purchase by Alan Armstrong dated Mar 27, 2026, disclosed Jul 21, 2026. How late filing is measured across all of Congress is in the late-filers study.
44 of the 47 trades that list an account holder (94%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Rohit Khanna filed the most $ABBV purchases (16), and Rohit Khanna the most sales (18).
Activity peaked in 2025 with 19 trades. The busiest single month was May 2025, when 3 different members disclosed $ABBV trades. In 1 calendar month out of 29 with activity, three or more members bought $ABBV in the same month, the same-direction overlap Coldpine's cluster detector looks for.
Across the 30 purchases Coldpine can price, $ABBV moved +3.34% on average between the trade date and the disclosure date, against +1.51% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 67% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.
Members who trade ABBV
Recent disclosed trades in ABBV
| Date | Member | Type | Amount |
|---|---|---|---|
| Sep 14 | Pete Sessions(TX) | sell | $15K–$50K |
| Sep 4 | Rohit Khanna(CA) | sell | $15K–$50K |
| Jun 2 | Rohit Khanna(CA) | buy | $1K–$15K |
| May 5 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Apr 13 | Rohit Khanna(CA) | sell | $15K–$50K |
| Mar 27 | Alan Armstrong(OK) | buy | $15K–$50K |
| Aug 4 | Marjorie Taylor Greene(GA) | buy | $1K–$15K |
| Jul 1 | Rohit Khanna(CA) | sell | — |
| May 28 | Rohit Khanna(CA) | buy | $15K–$50K |
| May 22 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| May 15 | Rob Bresnahan(PA) | buy | $1K–$15K |
| Apr 7 | Jared Moskowitz(FL) | buy | $1K–$15K |
| Apr 3 | Dwight Evans(PA) | sell | $1K–$15K |
| Mar 17 | Marjorie Taylor Greene(GA) | buy | $1K–$15K |
| Mar 6 | Rohit Khanna(CA) | buy | $1K–$15K |
| Feb 19 | Rohit Khanna(CA) | buy | $15K–$50K |
| Feb 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Feb 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Feb 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Feb 4 | Rohit Khanna(CA) | sell | $1K–$15K |
Showing 20 of 58 disclosed trades.
Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).
Create a free accountFrom Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →